SCHEMBL3611526

SCHEMBL3611526

COc1ccc(COc2cc(Oc3c(CC#N)c(C)nn3C)c(Cl)cc2Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP2C19 P33261 1/20 0.39
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
ATP4A P20648 1/20 0.35
MAPK1 P28482 1/20 0.35
ATP4B P51164 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3610821 0.95 ALDH1A1 (0.37) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3612786 0.88 ALDH1A1 (0.39) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3597738 0.87 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3615067 0.85 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3610486 0.84 PTGDR2 (0.49) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3612382 0.82 PDE2A (0.41) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3607959 0.81 GAA (0.38) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3612420 0.80 SMN1; SMN2 (0.53) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3604681 0.80 SMN1; SMN2 (0.40) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19
SCHEMBL3613236 0.80 KDM4E (0.54) ALDH1A1CYP1A2CYP2C9KDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2128138-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R ALDH1A1 365/4885CYP1A2 137/4885CYP2C9 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.